Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cheng

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Journal of Virology|September 29, 2005
De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infectionTodd M Allen, Xu G Yu, Elizabeth T Kalife, et al.
Science Immunology|March 10, 2023
Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancerYini Zhu, Yun Zhao, Jiling Wen, et al.
Signal Transduction and Targeted Therapy|September 29, 2025
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistanceClaire M Storey, Mohamed Altai, Katharina Lückerath, et al.
ACS Nano|April 8, 2020
Nanoparticle Uptake in a Spontaneous and Immunocompetent Woodchuck Liver Cancer ModelLewis Y Liu, Xue-Zhong Ma, Ben Ouyang, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Journal of Virology|September 29, 2005
De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infectionTodd M Allen, Xu G Yu, Elizabeth T Kalife, et al.
Science Immunology|March 10, 2023
Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancerYini Zhu, Yun Zhao, Jiling Wen, et al.
Signal Transduction and Targeted Therapy|September 29, 2025
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistanceClaire M Storey, Mohamed Altai, Katharina Lückerath, et al.
ACS Nano|April 8, 2020
Nanoparticle Uptake in a Spontaneous and Immunocompetent Woodchuck Liver Cancer ModelLewis Y Liu, Xue-Zhong Ma, Ben Ouyang, et al.
Pageof 10